Janet L Karlix
Overview
Explore the profile of Janet L Karlix including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamilton E, Wang J, Oza A, Patel M, Ulahannan S, Bauer T, et al.
Mol Cancer Ther
. 2023 Jul;
22(10):1154-1165.
PMID: 37486983
AZD5153, a reversible, bivalent inhibitor of the bromodomain and extraterminal family protein BRD4, has preclinical activity in multiple tumors. This first-in-human, phase I study investigated AZD5153 alone or with olaparib...
2.
Lim E, Bendell J, Falchook G, Bauer T, Drake C, Choe J, et al.
Clin Cancer Res
. 2022 Aug;
28(22):4871-4884.
PMID: 36044531
Purpose: To evaluate AZD4635, an adenosine A2A receptor antagonist, as monotherapy or in combination with durvalumab in patients with advanced solid tumors. Patients And Methods: In phase Ia (dose escalation),...
3.
Formea C, Evans C, Karlix J
Pharmacotherapy
. 2005 Jul;
25(7):1021-9.
PMID: 16006281
A 19-year-old woman was admitted to receive a kidney transplant from a nonliving donor. At the time of transplantation, she was taking oral phenytoin 300 mg every morning, 100 mg...
4.
Formea C, Myers-Huentelman H, Wu R, Crabtree J, Fujita S, Hemming A, et al.
Am J Transplant
. 2004 Oct;
4(11):1810-7.
PMID: 15476481
Azathioprine (AZA) is an immunosuppressive prodrug that undergoes metabolism by thiopurine S-methyltransferase (TPMT). Eighty to ninety-five percent of low or deficient TPMT enzyme activity is genetically determined by the presence...
5.
Kahan B, Karlix J, Ferguson R, Leichtman A, Mulgaonkar S, Gonwa T, et al.
Transplantation
. 2003 Oct;
76(7):1079-84.
PMID: 14557756
Background: FTY720, a novel immunomodulator, displays potent immunosuppressive activity in a variety of preclinical transplant models. This study examined the safety, pharmacodynamics, and pharmacokinetics of multiple doses of FTY720 in...
6.
Howard R, Thai V, Patton P, Hemming A, Reed A, Van der Werf W, et al.
Transplantation
. 2002 Jan;
73(1):53-5.
PMID: 11792977
Background: Kidney transplant programs may avoid transplantation in obese patients because of reports indicating that obese patients have poorer outcomes than do nonobese patients. We recently reviewed our experience. Methods:...